Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive interest in smaller AI ...

Abstract: Deep learning methods have recently shown significant promise in compressing the geometric features of point clouds. However, challenges arise when consecutive point clouds contain holes, ...

Cathie Wood is resolute on RXRX despite its slump. Should investors follow her lead into this AI-driven biotech bet now?

Abstract: Renewable energy sources and electric vehicles provide an effective way to reduce the energy cost of an enterprise microgrid. However, the uncertainties of renewable energy sources and the ...

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Ethereum Foundation set 2026 zkEVM security targets using soundcalc. ETH also nears a multi month trendline test near $3,030.

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during ...